
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss another rough week for biotech stocks, Valeant Pharmaceuticals' doggedness in the face of congressional inquiry, and a curious new trend in pharma advertising.
Biotech's Wall Street malaise, Valeant's Washington woes, and immuno-oncology's primetime slot is an episode from FierceBiotech Radio. Fierce editors discuss another rough week for biotech stocks, Valeant Pharmaceuticals' doggedness in the...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Oct 8, 2015, 26:30 long, audio available.